Trinseo extends waiver deadlines on revolver, senior, refinance, securitization facilities to May 13-14, 2026

This filing

As permitted by the waiver under the Company’s super-priority revolving credit facility dated January 17, 2025, the counterparties confirmed the extension of such waiver’s expiration date until May 13, 2026.

Comparable filing

On May 5, 2026, HNO International, Inc. (the "Company") entered into a Securities Purchase Agreement (the "MSC Purchase Agreement") with Monroe Street Capital Partners, LP, a Delaware limited partnership (the "MSC Buyer"), pursuant to which the Company issued to the MSC Buyer a Convertible Promissory Note in the principal amount of $67,500

This filing

As permitted by the waiver under the Company’s super-priority revolving credit facility dated January 17, 2025, the counterparties confirmed the extension of such waiver’s expiration date until May 13, 2026.

Comparable filing

On May 5, 2026 (the “Second Amendment Effective Date”), PEDEVCO Corp., a Texas corporation (the “Company”), entered into a Second Amendment to Credit Agreement (the “Second Amendment”) with Citibank, N.A., as administrative agent (the “Administrative Agent”), each of the guarantors party thereto, and each of the lenders party thereto.

This filing

As permitted by the waiver under the Company’s super-priority revolving credit facility dated January 17, 2025, the counterparties confirmed the extension of such waiver’s expiration date until May 13, 2026.

Comparable filing

On May 5, 2026, American Honda Receivables LLC ("AHR LLC") and American Honda Finance Corporation ("AHFC") entered into an Underwriting Agreement with Barclays Capital Inc. ("Barclays"), Mizuho Securities USA LLC ("Mizuho"), SMBC Nikko Securities America, Inc. ("SMBC Nikko") and SG Americas Securities, LLC ("SG"), each on behalf of itself and as a representative of the several underwriters, for the sale of certain notes of Honda Auto Receivables 2026-2 Owner Trust (the "Issuer"), in the following classes and in the amounts described therein: Class A-1 3.828% Asset Backed Notes (the "Class A-1 Notes"), Class A-2a 4.11% Asset Backed Notes (the "Class A-2a Notes"), Class A-2b SOFR Rate + 0.38% Asset Backed Notes (the "Class A-2b Notes"), Class A-3 4.30% Asset Backed Notes (the "Class A-3 Notes") and Class A-4 4.33% Asset Backed Notes (the "Class A-4 Notes") (collectively, the "Underwritten Notes"). The Underwritten Notes will be issued on or about May 13, 2026 (the "Closing Date"). AHFC w

This filing

As permitted by the waiver under the Company’s super-priority revolving credit facility dated January 17, 2025, the counterparties confirmed the extension of such waiver’s expiration date until May 13, 2026.

Comparable filing

the Fund entered into a Registration Rights Agreement, dated as of May 7, 2026 (the “ Registration Rights Agreement ”), with Goldman Sachs & Co. LLC, ING Financial Markets LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC as the representatives of the Initial Purchasers of the Notes.

This filing

As permitted by the waiver under the Company’s super-priority revolving credit facility dated January 17, 2025, the counterparties confirmed the extension of such waiver’s expiration date until May 13, 2026.

Comparable filing

On May 11, 2026, Accendra Health, Inc. (the “ Company ”) entered into a Commitment and Consent Letter (the “ Commitment Letter ”) with certain institutions that are (a)(i) holders of the Company’s 4.500% Senior Notes due 2029 (the “ 2029 Notes ”) and 6.625% Senior Notes due 2030 (the “ 2030 Notes ” and, together with the 2029 Notes, the “ Existing Notes ”), collectively holding approximately all of the outstanding principal amount of the 2029 Notes and approximately 83% of the outstanding principal amount of the 2030 Notes as of May 11, 2026 and (ii) lenders under the Company’s existing Term Loan Credit Agreement (as defined below) (collectively, the “ Commitment and Consenting Parties ” and each, a “ Commitment and Consenting Party ”), (b) certain lenders under the Company’s existing Term Loan Credit Agreement consenting solely with respect to the Term B-1 Term Loan Consent (as defined below) (the “ Term B-1 Term Loan Consenting Parties ”) and (c) all lenders under the Company’s Exist

This filing

As permitted by the waiver under the Company’s super-priority revolving credit facility dated January 17, 2025, the counterparties confirmed the extension of such waiver’s expiration date until May 13, 2026.

Comparable filing

On May 7, 2026, Evolution Metals & Technologies Corp. (“EMAT” or the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with YA II PN, LTD. (“Yorkville”), a fund managed by Yorkville Advisors Global, LP, pursuant to which the Company agreed to issue and sell to Yorkville convertible debentures in the aggregate principal amount of up to $100,000,000

This filing

As permitted by the waiver under the Company’s super-priority revolving credit facility dated January 17, 2025, the counterparties confirmed the extension of such waiver’s expiration date until May 13, 2026.

Comparable filing

On May 4, 2026, Renasant Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Keefe, Bruyette & Woods, Inc. and Stephens Inc., as representatives of the underwriters listed on Schedule I to the Underwriting Agreement, for the issuance and sale of $300 million aggregate principal amount of its 6.25% Fixed-to-Floating Rate Subordinated Notes due 2036

This filing

As permitted by the waiver under the Company’s super-priority revolving credit facility dated January 17, 2025, the counterparties confirmed the extension of such waiver’s expiration date until May 13, 2026.

Comparable filing

On May 26, 2026, LiqTech International, Inc. (the “Company”) entered into a Debt Cancellation Agreement (the “Debt Cancellation Agreement”) with affiliates of Bleichroeder L.P., 21 April Fund, L.P., and 21 April Fund, Ltd. (the “Note Holders”).